OLIGOMETASTATIC PROSTATE CANCER
Clinical trials for OLIGOMETASTATIC PROSTATE CANCER explained in plain language.
Never miss a new study
Get alerted when new OLIGOMETASTATIC PROSTATE CANCER trials appear
Sign up with your email to follow new studies for OLIGOMETASTATIC PROSTATE CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for men with spread prostate cancer: targeted radiation may boost standard care
Disease control Recruiting nowThis study is for men with prostate cancer that has spread to a few other parts of the body at diagnosis. It tests whether adding radiation therapy directly to those cancer spots (called metastasis-directed radiotherapy) can help keep the cancer under control longer than the usua…
Matched conditions: OLIGOMETASTATIC PROSTATE CANCER
Phase: PHASE2 • Sponsor: Case Comprehensive Cancer Center • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
New trial tests faster radiation for men with spread prostate cancer
Disease control Recruiting nowThis study compares standard moderate radiation (4 weeks) with shorter, more intense radiation schedules (1-2 weeks or a single session) for treating the prostate in men whose cancer has spread to a few other spots (oligometastatic). The goal is to see if the shorter treatments a…
Matched conditions: OLIGOMETASTATIC PROSTATE CANCER
Phase: NA • Sponsor: British Columbia Cancer Agency • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
MRI-Guided radiation zaps prostate tumors with fewer side effects?
Disease control Recruiting nowThis study tests a new type of radiation therapy for prostate cancer that uses an MRI machine to guide the beam in real time. The goal is to deliver high doses of radiation more precisely to the tumor while sparing healthy tissue. The trial will enroll 50 men with localized or li…
Matched conditions: OLIGOMETASTATIC PROSTATE CANCER
Phase: NA • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
New combo therapy aims to stall prostate cancer spread
Disease control Recruiting nowThis phase II trial tests whether adding a radioactive drug called Lu-PSMA to precise radiation therapy can better control prostate cancer that has spread to just 1-3 spots. About 70 men with hormone-sensitive prostate cancer will be randomly assigned to get radiation alone or ra…
Matched conditions: OLIGOMETASTATIC PROSTATE CANCER
Phase: PHASE2 • Sponsor: Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
Triple-Drug attack before prostate surgery shows promise in early trial
Disease control Recruiting nowThis study tests whether adding two drugs—fasudil hydrochloride and a PD-1 inhibitor—to standard hormone therapy before prostate cancer surgery can better shrink or eliminate tumors. About 83 men with locally advanced or limited metastatic prostate cancer will receive either the …
Matched conditions: OLIGOMETASTATIC PROSTATE CANCER
Phase: PHASE2, PHASE3 • Sponsor: baotai Liang • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
New combo therapy aims to wipe out prostate tumors before surgery
Disease control Recruiting nowThis Phase 2 trial tests whether adding homoharringtonine, a drug from a plant, to standard hormone therapy can better shrink or eliminate prostate cancer before surgery. About 96 men with locally advanced or limited spread prostate cancer will receive either the drug combo or a …
Matched conditions: OLIGOMETASTATIC PROSTATE CANCER
Phase: PHASE2 • Sponsor: baotai Liang • Aim: Disease control
Last updated Jun 26, 2026 14:51 UTC
-
Mapping Cancer's next move: study tracks where prostate cancer returns after aggressive radiotherapy
Knowledge-focused Recruiting nowThis study follows 700 men with prostate cancer that has spread to up to 10 spots in the body (oligometastatic). All receive radiotherapy to the prostate and to each visible metastasis, along with standard systemic therapy. Researchers collect real-world data from medical records…
Matched conditions: OLIGOMETASTATIC PROSTATE CANCER
Sponsor: Affidea Nu-med Center of Oncological DIagnostics and Therapy • Aim: Knowledge-focused
Last updated Jul 08, 2026 00:00 UTC